Kv1.3 inhibition attenuates neuroinflammation through disruption of microglial calcium signaling

References

• DeCoursey TE, Chandy KG, Gupta S, et al. Voltage-gated K+ channels in human T lymphocytes: a role in mitogenesis? Nature. 1984;307(5950):465–468.
   PubMed Web of Science ®Google Scholar
• Beeton C, Wulff H, Standifer NE, et al. Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc Natl Acad Sci USA. 2006;103(46):17414–17419.
   PubMed Web of Science ®Google Scholar
• Tarcha EJ, Chi V, Munoz-Elias EJ, et al. Durable pharmacological responses from the peptide ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune disease. J Pharmacol Exp Ther. 2012;342(3):642–653.
   PubMed Web of Science ®Google Scholar
• Chandy KG, Norton RS. Peptide blockers of Kv1.3 channels in T cells as therapeutics for autoimmune disease. Curr Opin Chem Biol. 2017;38:97–107.
   PubMed Web of Science ®Google Scholar
• Chen YJ, Nguyen HM, Maezawa I, et al. Inhibition of the potassium channel Kv1.3 reduces infarction and inflammation in ischemic stroke. Ann Clin Transl Neurol. 2018;5(2):147–161.
   PubMed Web of Science ®Google Scholar
• Ma DC, Zhang NN, Zhang YN, et al. Kv1.3 channel blockade alleviates cerebral ischemia/reperfusion injury by reshaping M1/M2 phenotypes and compromising the activation of NLRP3 inflammasome in microglia. Exp Neurol. 2020;332:113399.
   PubMed Web of Science ®Google Scholar
• Maezawa I, Nguyen HM, Di Lucente J, et al. Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer’s disease: preclinical proof of concept. Brain. 2018;141(2):596–612.
   PubMedGoogle Scholar
• Sarkar S, Nguyen HM, Malovic E, et al. Kv1.3 modulates neuroinflammation and neurodegeneration in Parkinson’s disease. J Clin Invest. 2020;130(8):4195–4212.
   PubMed Web of Science ®Google Scholar
• Reeves TM, Trimmer PA, Colley BS, et al. Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury. Exp Neurol. 2016;283(PtA):188–203.
   PubMedGoogle Scholar
• Lai IK, Valdearcos M, Morioka K, et al. Blocking Kv1.3 potassium channels prevents postoperative neuroinflammation and cognitive decline without impairing wound healing in mice. Br J Anaesth. 2020;125(3):298–307.
   PubMed Web of Science ®Google Scholar
• Peng Y, Lu K, Li Z, et al. Blockade of Kv1.3 channels ameliorates radiation-induced brain injury. Neuro Oncol. 2014;16(4):528–539.
   PubMed Web of Science ®Google Scholar
• Chen YJ, Nguyen HM, Maezawa I, et al. The potassium channel KCa3.1 constitutes a pharmacological target for neuroinflammation associated with ischemia/reperfusion stroke. J Cereb Blood Flow Metab. 2016;36(12):2146–2161.
   PubMed Web of Science ®Google Scholar
• Rangaraju S, Gearing M, Jin LW, et al. Potassium channel Kv1.3 is highly expressed by microglia in human Alzheimer’s disease. J Alzheimers Dis. 2015;44(3):797–808.
   PubMed Web of Science ®Google Scholar
• Norenberg W, Gebicke-Haerter PJ, Illes P. Inflammatory stimuli induce a new K+ outward current in cultured rat microglia. Neurosci Lett. 1992;147(2):171–174.
   PubMed Web of Science ®Google Scholar
• Kotecha SA, Schlichter LC. A Kv1.5 to Kv1.3 switch in endogenous hippocampal microglia and a role in proliferation. J Neurosci. 1999;19(24):10680–10693.
   PubMed Web of Science ®Google Scholar
• Fordyce CB, Jagasia R, Zhu X, et al. Microglia Kv1.3 channels contribute to their ability to kill neurons. J Neurosci. 2005;25(31):7139–7149.
   PubMed Web of Science ®Google Scholar
• Nguyen HM, Grossinger EM, Horiuchi M, et al. Differential Kv1.3, KCa3.1, and Kir2.1 expression in “classically” and “alternatively” activated microglia. Glia. 2017;65(1):106–121.
   PubMed Web of Science ®Google Scholar
• Di Lucente J, Nguyen HM, Wulff H, et al. The voltage-gated potassium channel Kv1.3 is required for microglial pro-inflammatory activation in vivo. Glia. 2018;66(9):1881–1895.
   PubMed Web of Science ®Google Scholar
• Perry VH, Nicoll JA, Holmes C. Microglia in neurodegenerative disease. Nat Rev Neurol. 2010;6(4):193–201.
   PubMed Web of Science ®Google Scholar
• Franco R, Fernandez-Suarez D. Alternatively activated microglia and macrophages in the central nervous system. Prog Neurobiol. 2015;131:65–86.
   PubMed Web of Science ®Google Scholar
• Murray PJ, Allen JE, Biswas SK, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014;41(1):14–20.
   PubMed Web of Science ®Google Scholar
• Khanna R, Roy L, Zhu X, et al. K+ channels and the microglial respiratory burst. Am J Physiol Cell Physiol. 2001;280(4):C796–806.
   PubMed Web of Science ®Google Scholar
• Kim C, Ho DH, Suk JE, et al. Neuron-released oligomeric alpha-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia. Nat Commun. 2013;4:1562.
   PubMed Web of Science ®Google Scholar
• Liu J, Xu C, Chen L, et al. Involvement of Kv1.3 and p38 MAPK signaling in HIV-1 glycoprotein 120-induced microglia neurotoxicity. Cell Death Dis. 2012;3:e254.
   PubMed Web of Science ®Google Scholar
• Liu J, Xu P, Collins C, et al. HIV-1 Tat protein increases microglial outward K+ current and resultant neurotoxic activity. PLoS One. 2013;8(5):e64904.
   PubMed Web of Science ®Google Scholar
• Rangaraju S, Raza SA, Pennati A, et al. A systems pharmacology-based approach to identify novel Kv1.3 channel-dependent mechanisms in microglial activation. J Neuroinflammation. 2017;14(1):128.
   PubMedGoogle Scholar
• Rangaraju S, Dammer EB, Raza SA, et al. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease. Mol Neurodegener. 2018;13(1):24.
   PubMedGoogle Scholar
• Lam D, Lively S, Schlichter LC. Responses of rat and mouse primary microglia to pro- and anti-inflammatory stimuli: molecular profiles, K+ channels and migration. J Neuroinflammation. 2017;14(1):166.
   PubMedGoogle Scholar
• Feske S, Wulff H, Skolnik EY. Ion Channels in Innate and Adaptive Immunity. Annu Rev Immunol. 2015;33:291–353.
   PubMed Web of Science ®Google Scholar
• Lyons SA, Pastor A, Ohlemeyer C, et al. Distinct physiologic properties of microglia and blood-borne cells in rat brain slices after permanent middle cerebral artery occlusion. J Cereb Blood Flow Metab. 2000;20(11):1537–1549.
   PubMed Web of Science ®Google Scholar
• Boucsein C, Zacharias R, Farber K, et al. Purinergic receptors on microglial cells: functional expression in acute brain slices and modulation of microglial activation in vitro. Eur J Neurosci. 2003;17(11):2267–2276.
   PubMed Web of Science ®Google Scholar
• Negulescu PA, Shastri N, Cahalan MD. Intracellular calcium dependence of gene expression in single T lymphocytes. Proc Natl Acad Sci U S A. 1994;91(7):2873–2877.
   PubMed Web of Science ®Google Scholar
• Cahalan MD, Chandy KG. The functional network of ion channels in T lymphocytes. Immunol Rev. 2009;231(1):59–87.
   PubMedGoogle Scholar
• Panicker N, Saminathan H, Jin H, et al. Fyn kinase regulates microglial neuroinflammatory responses in cell culture and animal models of Parkinson’s disease. J Neurosci. 2015;35(27):10058–10077.
   PubMed Web of Science ®Google Scholar
• Lewis RS, Cahalan MD. Potassium and calcium channels in lymphocytes. Annu Rev Immunol. 1995;13:623–653.
   PubMed Web of Science ®Google Scholar
• Leonard RJ, Garcia ML, Slaughter RS, et al. Selective blockers of voltage-gated K+ channels depolarize human T lymphocytes: mechanism of the antiproliferative effect of charybdotoxin. Proc Natl Acad Sci U S A. 1992;89(21):10094–10098.
   PubMed Web of Science ®Google Scholar
• Eder C. Ion channels in microglia (brain macrophages). Am J Physiol. 1998;275(2):C327–42.
   PubMedGoogle Scholar
• Kettenmann H, Hanisch UK, Noda M, et al. Physiology of microglia. Physiol Rev. 2011;91(2):461–553.
   PubMed Web of Science ®Google Scholar
• Madry C, Kyrargyri V, Arancibia-Carcamo IL, et al. Microglial ramification, surveillance, and interleukin-1beta release are regulated by the two-pore domain K(+) channel THIK-1. Neuron. 2018;97(2):299–312 e6.
   PubMed Web of Science ®Google Scholar
• Nguyen HM, Di Lucente J, Chen YJ, et al. Biophysical basis for Kv1.3 regulation of membrane potential changes induced by P2X4-mediated calcium entry in microglia. Glia. 2020;68(11):2377–2394.
   PubMed Web of Science ®Google Scholar
• Pankratov Y, Lalo U, Verkhratsky A, et al. Vesicular release of ATP at central synapses. Pflugers Arch. 2006;452(5):589–597.
   PubMed Web of Science ®Google Scholar
• Visentin S, Renzi M, Frank C, et al. Two different ionotropic receptors are activated by ATP in rat microglia. J Physiol. 1999;519(Pt 3):723–736.
   PubMed Web of Science ®Google Scholar
• Wixey JA, Reinebrant HE, Carty ML, et al. Delayed P2X4R expression after hypoxia-ischemia is associated with microglia in the immature rat brain. J Neuroimmunol. 2009;212(1–2):35–43.
   PubMed Web of Science ®Google Scholar
• Cavaliere F, Florenzano F, Amadio S, et al. Up-regulation of P2X2, P2X4 receptor and ischemic cell death: prevention by P2 antagonists. Neuroscience. 2003;120(1):85–98.
   PubMed Web of Science ®Google Scholar
• Li F, Wang L, Li JW, et al. Hypoxia induced amoeboid microglial cell activation in postnatal rat brain is mediated by ATP receptor P2X4. BMC Neurosci. 2011;12:111.
   PubMed Web of Science ®Google Scholar
• Gao T, Raza SA, Ramesha S, et al. Temporal profiling of Kv1.3 channel expression in brain mononuclear phagocytes following ischemic stroke. J Neuroinflammation. 2019;16(1):116.
   PubMedGoogle Scholar
• McLarnon JG. Purinergic mediated changes in Ca2+ mobilization and functional responses in microglia: effects of low levels of ATP. J Neurosci Res. 2005;81(3):349–356.
   PubMed Web of Science ®Google Scholar
• Verheugen JA, Vijverberg HP, Oortgiesen M, et al. Voltage-gated and Ca2+-activated K+ channels in intact human T lymphocytes. Noninvasive measurements of membrane currents, membrane potential, and intracellular calcium. J Gen Physiol. 1995;105(6):765–794.
   PubMed Web of Science ®Google Scholar
• Hahn J, Jung W, Kim N, et al. Characterization and regulation of rat microglial Ca2+ release-activated Ca2+ (CRAC) channel by protein kinases. Glia. 2000;31(2):118–124.
   PubMed Web of Science ®Google Scholar
• Beck A, Penner R, Fleig A. Lipopolysaccharide-induced down-regulation of Ca2+ release-activated Ca2+ currents (I CRAC) but not Ca2+-activated TRPM4-like currents (I CAN) in cultured mouse microglial cells. J Physiol. 2008;586(2):427–439.
   PubMed Web of Science ®Google Scholar
• Ohana L, Newell EW, Stanley EF, et al. The Ca2+ release-activated Ca2+ current (I(CRAC)) mediates store-operated Ca2+ entry in rat microglia. Channels (Austin). 2009;3(2):129–139.
   PubMed Web of Science ®Google Scholar
• Michaelis M, Nieswandt B, Stegner D, et al. STIM1, STIM2, and Orai1 regulate store-operated calcium entry and purinergic activation of microglia. Glia. 2015;63(4):652–663.
   PubMed Web of Science ®Google Scholar
• Mizuma A, Kim JY, Kacimi R, et al. Microglial calcium release-activated calcium channel inhibition improves outcome from experimental traumatic brain injury and microglia-induced neuronal death. J Neurotrauma. 2019;36(7):996–1007.
   PubMed Web of Science ®Google Scholar
• Hoffmann A, Kann O, Ohlemeyer C, et al. Elevation of basal intracellular calcium as a central element in the activation of brain macrophages (microglia): suppression of receptor-evoked calcium signaling and control of release function. J Neurosci. 2003;23(11):4410–4419.
   PubMed Web of Science ®Google Scholar
• Chung S, Lee MY, Soh H, et al. Modulation of membrane potential by extracellular pH in activated microglia in rats. Neurosci Lett. 1998;249(2–3):139–142.
   PubMed Web of Science ®Google Scholar
• Dadsetan S, Zakharova L, Molinski TF, et al. Store-operated Ca2+ influx causes Ca2+ release from the intracellular Ca2+ channels that is required for T cell activation. J Biol Chem. 2008;283(18):12512–12519.
   PubMed Web of Science ®Google Scholar
• Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260(6):3440–3450.
   PubMed Web of Science ®Google Scholar
• Wang RE, Wang Y, Zhang Y, et al. Rational design of a Kv1.3 channel-blocking antibody as a selective immunosuppressant. Proc Natl Acad Sci USA. 2016;113(41):11501–11506.
   PubMed Web of Science ®Google Scholar
• Bednenko J, Harriman R, Marien L, et al. A multiplatform strategy for the discovery of conventional monoclonal antibodies that inhibit the voltage-gated potassium channel Kv1.3. MAbs. 2018;10(4):636–650.
   PubMed Web of Science ®Google Scholar
• Grissmer S, Dethlefs B, Wasmuth JJ, et al. Expression and chromosomal localization of a lymphocyte K+ channel gene. Proc Natl Acad Sci U S A. 1990;87(23):9411–9415.
   PubMed Web of Science ®Google Scholar
• Gutman GA, Chandy KG, Grissmer S, et al. International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol Rev. 2005;57(4):473–508.
   PubMed Web of Science ®Google Scholar